IthaID: 328

Names and Sequences

Functionality: Globin gene causative mutation Pathogenicity: N/A
Common Name: --CANT HGVS Name: NC_000016.10:g.(168531_169756)_(182770_183028)del
Hb Name: N/A Protein Info: N/A

Also known as:

Comments: The deletion was reported in a father and his two children from Northern Spain. They were clinically asymptomatic with a slight microcytic anaemia. Restriction enzyme digestion was used to approximate positions of breakpoints. The 5 ’breakpoint is localised upstream of the HBA2 gene, in a region that harbors the HBAP1 gene, between the restriction enzyme sites AccI (168531) and HpaI (169756). More evidence is needed to accurate whether or not the HBAP1 gene is deleted. The 3’ breakpoint is localized upstream of the HBQ1 gene, presumably between the restriction enzyme sites HindIII (182770) and BamHI (183028) (coordinates: GRCh38.p12, NC_000016.10). As the breakpoints are not clearly defined, the deletion size shown on the sequence viewer is just an approximation.

We follow the HGVS sequence variant nomenclature and IUPAC standards.

External Links


Hemoglobinopathy Group: Thalassaemia
Hemoglobinopathy Subgroup: α-thalassaemia
Allele Phenotype:α0
Associated Phenotypes: Haemolytic anaemia [HP:0001878]


Chromosome: 16
Locus: NG_000006.1
Locus Location: 29394
Size: 14.497 kb
Deletion involves: α2, α1

Other details

Type of Mutation: Deletion
Ethnic Origin: Spanish
Molecular mechanism: N/A
Inheritance: Recessive
DNA Breakpoint Determined: No

In silico pathogenicity prediction

Publications / Origin

  1. Villegas A, Sanchez J, Ricard P, Gonzalez FA, Del Potro E, Armada B, Carreno DL, Espinos D, Characterization of a new alpha-thalassemia-1 mutation in a Spanish family., Hemoglobin , 18(1), 29-37, 1994
Created on 2010-06-16 16:13:15, Last reviewed on 2020-03-12 11:04:28 (Show full history)

Disclaimer: The information on this website is provided as an information resource only and must not to be used as a substitute for professional diagnosis and treatment. The ITHANET Portal and IthaGenes are not responsible or liable for any advice, course of treatment, diagnosis or any other information, services or products that an individual obtains through this website.